美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LeonaBio Inc

9.68

+0.65007.20%

盤後：9.680.00000.00%16:10 EDT

成交量：12.59萬

成交額：117.41萬

市值：9,037.15萬

市盈率：-1.00

高：9.79

開：8.90

低：8.76

收：9.03

52周最高：14.21

52周最低：2.20

股本：933.59萬

流通股本：256.85萬

量比：1.21

換手率：4.90%

股息：- -

股息率：- -

每股收益(TTM):-9.6552

每股收益(LYR):-25.1917

淨資產收益率：-89.42%

總資產收益率：-42.21%

市淨率：3.37

市盈率(LYR):-0.38

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

LeonaBio Inc

交易所：

NASDAQ

成立時間：

2011

員工人數：

26

公司地址：

18706 North Creek Parkway,Suite 104,Bothell,Washington,United States

官網：

http://www.leonabio.com

郵編：

98011

電話：

傳真：

- -

簡介：

LeonaBio, Inc.於2011年3月31日在華盛頓州註冊成立為M3 Biotechnology，Inc.，並於2015年10月27日在特拉華州重新註冊為股份公司。該公司是一家處於臨床後期階段的生物製藥公司，致力於開發小型藥物分子來恢復神經元健康並阻止神經變性。其主要藥物候選者lasofoxifene和ATH-1105是新型小分子療法，旨在針對當前治療選擇有限或無效的破壞性疾病。LeonaBio 堅持追求科學卓越和以患者為中心的創新，致力於為最需要幫助的人開發具有實際意義的新療法。

董事

名稱

職位

Leen Kawas

President, Chief Executive Officer and Director

Tadataka Yamada

Chairman of the Board

James A. Johnson

Director

John M. Fluke, Jr.

Director

Joseph Edelman

Director

股東

名稱

職位

Leen Kawas

President, Chief Executive Officer and Director

Mark Litton

Chief Operating Officer

Glenna Mileson

Chief Financial Officer and Corporate Secretary

Hans Moebius

Chief Medical Officer

Kevin Church

Vice President of Discovery

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LONA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LONA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":9.68,"timestamp":1774555200000,"preClose":9.03,"halted":0,"volume":125941,"hourTrading":{"tag":"盘后","latestPrice":9.68,"preClose":9.68,"latestTime":"16:10 EDT","volume":111,"amount":1074.48,"timestamp":1774555805150,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07198228128460692,"floatShares":2568500,"shares":9335900,"eps":-9.65516,"marketStatus":"盤後交易","change":0.65,"latestTime":"03-26 16:23:26 EDT","open":8.9,"high":9.79,"low":8.7601,"amount":1174101.4356,"amplitude":0.114053,"askPrice":10.98,"askSize":100,"bidPrice":9.25,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-9.65516,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":9.03,"postHourTrading":{"tag":"盘后","latestPrice":9.68,"preClose":9.68,"latestTime":"16:10 EDT","volume":111,"amount":1074.48,"timestamp":1774555805150,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.208341},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","floatShares":2568500,"roa":"-42.21%","roe":"-89.42%","lyrEps":-25.191731,"volumeRatio":1.208341,"shares":9335900,"dividePrice":0,"high":9.79,"amplitude":0.114053,"preClose":9.03,"low":8.7601,"week52Low":2.1955,"pbRate":"3.37","week52High":14.21,"institutionHeld":0,"latestPrice":9.68,"committee":-0.980198,"eps":-9.65516,"divideRate":0,"volume":125941,"delay":0,"ttmEps":-9.65516,"open":8.9,"prevYearClose":7.57,"prevWeekClose":9.92,"prevMonthClose":5.63,"prevQuarterClose":7.57,"fiveDayClose":9.93,"twentyDayClose":5.62,"sixtyDayClose":7.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LONA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"LONA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2025-09-18","symbol":"LONA","defaultRemindTime":1758202200000,"type":"split","dateTimestamp":1758168000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-08-07","symbol":"LONA","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-05-09","symbol":"LONA","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2025-02-27","symbol":"LONA","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盤後","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LONA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1772596800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LONA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LONA","date":"2026-03-25","current":-0.935251,"percent":0.102041,"low":-2.796591,"twenty":-1.615094,"median":-1.343012,"eighty":-1.127546,"high":-0.637746,"avg":-1.397935,"sd":0.501579,"marketCap":84209935},"quantilePoints":[{"date":"2026-01-16","current":-0.662315,"twenty":-0.686048,"median":-0.684271,"eighty":-0.675175,"marketCap":24984524},{"date":"2026-01-23","current":-1.56325,"twenty":-0.686675,"median":-0.673032,"eighty":-0.651338,"marketCap":58970481},{"date":"2026-01-30","current":-1.165659,"twenty":-1.344824,"median":-0.68793,"eighty":-0.65761,"marketCap":43972150},{"date":"2026-02-06","current":-1.185458,"twenty":-1.276038,"median":-1.158235,"eighty":-0.670888,"marketCap":44719023},{"date":"2026-02-13","current":-1.158234,"twenty":-1.22753,"median":-1.158234,"eighty":-0.684166,"marketCap":43692072},{"date":"2026-02-20","current":-1.368597,"twenty":-1.23248,"median":-1.158234,"eighty":-0.68542,"marketCap":51627598},{"date":"2026-02-27","current":-1.390871,"twenty":-1.374537,"median":-1.170609,"eighty":-0.765162,"marketCap":52467831},{"date":"2026-03-06","current":-1.329,"twenty":-1.392851,"median":-1.185458,"eighty":-1.076564,"marketCap":50133852},{"date":"2026-03-13","current":-1.856145,"twenty":-1.437398,"median":-1.225055,"eighty":-1.089928,"marketCap":70019347},{"date":"2026-03-20","current":-2.457536,"twenty":-1.517584,"median":-1.326525,"eighty":-1.109727,"marketCap":92705616},{"date":"2026-03-25","current":-2.232323,"twenty":-1.615094,"median":-1.343012,"eighty":-1.127546,"marketCap":84209935}],"updateTime":1774524818961},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":266015004,"yearFounded":2011,"employeeNum":26,"address":"18706 North Creek Parkway,Suite 104,Bothell,Washington,United States","zipCode":"98011","officePhone":"425 620 8501"},"stockCompanyDetail":{"websiteUrl":"http://www.leonabio.com","stockEarnings":[{"period":"1week","weight":-0.0767},{"period":"1month","weight":0.5569},{"period":"3month","weight":0.2524},{"period":"6month","weight":1.3394},{"period":"1year","weight":1.6931},{"period":"ytd","weight":0.1929}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"LeonaBio, Inc.於2011年3月31日在華盛頓州註冊成立為M3 Biotechnology，Inc.，並於2015年10月27日在特拉華州重新註冊為股份公司。該公司是一家處於臨床後期階段的生物製藥公司，致力於開發小型藥物分子來恢復神經元健康並阻止神經變性。其主要藥物候選者lasofoxifene和ATH-1105是新型小分子療法，旨在針對當前治療選擇有限或無效的破壞性疾病。LeonaBio 堅持追求科學卓越和以患者為中心的創新，致力於為最需要幫助的人開發具有實際意義的新療法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.081093},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02158},{"month":3,"riseRate":0.333333,"avgChangeRate":0.021478},{"month":4,"riseRate":0.4,"avgChangeRate":-0.068964},{"month":5,"riseRate":0.6,"avgChangeRate":0.065626},{"month":6,"riseRate":0.4,"avgChangeRate":-0.221545},{"month":7,"riseRate":0.6,"avgChangeRate":0.106269},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034355},{"month":9,"riseRate":0.2,"avgChangeRate":-0.224006},{"month":10,"riseRate":0.5,"avgChangeRate":0.036994},{"month":11,"riseRate":0.666667,"avgChangeRate":0.141696},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280766}],"exchange":"NASDAQ","name":"LeonaBio Inc","nameEN":"LeonaBio Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":{"directors":[{"name":"Leen Kawas","position":"President, Chief Executive Officer and Director"},{"name":"Tadataka Yamada","position":"Chairman of the Board"},{"name":"James A. Johnson","position":"Director"},{"name":"John M. Fluke, Jr.","position":"Director"},{"name":"Joseph Edelman","position":"Director"}],"executives":[{"name":"Leen Kawas","position":"President, Chief Executive Officer and Director"},{"name":"Mark Litton","position":"Chief Operating Officer"},{"name":"Glenna Mileson","position":"Chief Financial Officer and Corporate Secretary"},{"name":"Hans Moebius","position":"Chief Medical Officer"},{"name":"Kevin Church","position":"Vice President of Discovery"}]}}}